Kaidong Zhang
Fortuna: 21 675 $ al 31/08/2026
Fortuna: 21 675 $ al 31/08/2026
Kaidong Zhang is currently Chief Scientific Officer at PanGenomic Technologies Corp.
since 2020, Chief Scientific Officer at PanGenomic Health, Inc. since 2021, and Chief Technology Officer at Donglin Health Technologies, Inc. since 2018.
Formerly, Dr. Zhang was Director-Project Management at Biohop Technologies, Inc. from 2015 to 2020.
Education includes a doctorate from the University of Manitoba.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2025 | 72.250 ( 0,51 % ) | 21 675 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PANGENOMIC HEALTH INC. | Director Técnico/Científico/I+D | 01/11/2021 |
PanGenomic Technologies Corp.
PanGenomic Technologies Corp. Packaged SoftwareTechnology Services Develops a precision health platform | Director Técnico/Científico/I+D | 01/12/2020 |
Donglin Health Technologies, Inc. | Director Técnico/Científico/I+D | 01/01/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Biohop Technologies, Inc. | Corporate Officer/Principal | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PanGenomic Technologies Corp.
PanGenomic Technologies Corp. Packaged SoftwareTechnology Services Develops a precision health platform | Technology Services |
PanGenomic Health, Inc.
PanGenomic Health, Inc. Packaged SoftwareTechnology Services Develops a precision health platform | Technology Services |
Donglin Health Technologies, Inc. | |
Biohop Technologies, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.